Swiss biotech R&D investments reach record high 09-May-2022 By Rachel Arthur Capital investments in Swiss biotech companies reached CHF 3.33bn ($3.53bn) in 2021; while R&D investments increased to a record-high CHF 2.56bn ($2.71bn).